Suresh, Krithika
Dixon, Julia M.
Patel, Chandni
Beaty, Brenda
del Junco, Deborah J.
de Vries, Shaheem
Lategan, Hendrick J.
Steyn, Elmin
Verster, Janette
Schauer, Steven G.
Becker, Tyson E.
Cunningham, Cord
Keenan, Sean
Moore, Ernest E.
Wallis, Lee A.
Baidwan, Navneet
Fosdick, Bailey K.
Ginde, Adit A.
Bebarta, Vikhyat S.
Mould-Millman, Nee-Kofi https://orcid.org/0000-0003-4303-6903
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-19-2-0055, W81XWH-20-2-0042)
Article History
Received: 16 September 2022
Accepted: 1 October 2022
First Online: 17 October 2022
Declarations
:
: This study has received ethics approval with a waiver of informed consent at the patient level from the Health Research Ethics Committee at Stellenbosch University (N20/03/036 project ID 14866). The University of Colorado, Colorado Multiple Institutional Review Board (COMIRB) has ceded oversight to Stellenbosch University as the primary “single IRB” ethics committee responsible. In addition, the U.S. Army Medical Research and Development Command, Office of Research Protections, Human Research Protection Office (ORP HRPO) concluded that this study is no greater than minimal risk and complies with DOD subject protection requirements.
: Not applicable.
: The EpiC study has undergone peer-review by the United States Department of Defense funding body. The views expressed in this paper are those of the authors and do not represent the official position or policy of the University of Colorado, Stellenbosch University, Western Cape Department of Health, the U.S. Government, the U.S. Department of Defense, the U.S. Department of the Army, or the U.S. Department of the Air Force. The authors declare that they have no competing interest.